Washington, DC – November 9, 2020 – The Centers for Medicare and Medicaid Services (CMS) released its 2021 Star Ratings (covering calendar year 2019) in early October, and performance data show that Medicare Advantage health plans partnering with analytics and clinical services company RxAnte continue to outpace industry performance.
The Star Ratings, which measure managed care quality and members’ experience with their health plans, are released annually to allow consumers to compare the nearly 600 Medicare contracts administered by health plans.
RxAnte’s clients with four-star ratings entering this performance year improved medication adherence rates by twice as much as their 4-star peers, with some contracts improving the percentage of adherent members by as much as 5%. Additionally, nearly 90% of all quality measures managed by RxAnte are on a multi-year improvement trend, which is critical for plans working to stay above ever-increasing Star Ratings performance thresholds. Of the MAPD contracts RxAnte managed in both 2018 and 2019, 18% earned higher overall Star Ratings this year; this represents a 13% increase in improvement compared to other MAPD plans in the industry.
Looking ahead to 2022 Star Ratings, six RxAnte health plan clients have begun referring medically complex members to Mosaic, RxAnte’s comprehensive pharmacy service intervention, in order to improve adherence and manage costs of care. Launched in 2019, Mosaic uses new technologies to provide home-based services such as analytics-informed medication review and reconciliation, adherence packaging and delivery, and ongoing clinical monitoring for members managing chronic conditions with multiple daily medications.
With the launch of Mosaic Pharmacy Service, RxAnte has significantly extended its portfolio of patented analytics and intervention solutions for improving quality and lowering costs. “RxAnte is proud to help our health plan clients deliver high-quality managed pharmacy care to 14 million Americans. I’m especially excited that many of our clients are beginning to adopt our new Mosaic Pharmacy Service for their medically complex and vulnerable populations during the COVID-19 pandemic. We’re seeing promising early impacts on cost of care and pharmacy quality scores, and look forward to sharing this unique model for pharmacy services with more of our plan partners,” said Josh Benner, CEO and co-founder of RxAnte.
About Mosaic Pharmacy Service
Mosaic Pharmacy Service helps patients feel better about the medications they take every day. Mosaic combines proprietary technology with an intensive clinical pharmacy care model and home-based services to improve medication use and lower costs for patients taking several medications daily.
For health plans, Mosaic is a pharmacy partner that improves quality, medication costs, and healthcare utilization in medically complex Medicare populations.
RxAnte is dedicated to getting more from medicines using patented analytics and targeted clinical programs. A trusted provider of advanced analytics and targeted clinical programs for health plans and servicing more than 14 million lives, The RxAnte® systems, which are HITRUST- and SOC 2-certified, identify members at risk for drug therapy problems and support delivery of appropriate clinical interventions. Since 2011, this proven approach has enabled clients to improve CMS Star Ratings, HEDIS quality measures, and reduce total cost of care.